HELAX TMS BRACHYTHERAPY, VERSION 3.0
Device Facts
| Record ID | K962892 |
|---|---|
| Device Name | HELAX TMS BRACHYTHERAPY, VERSION 3.0 |
| Applicant | Siemens Medical Solutions USA, Inc. |
| Product Code | LNH · Radiology |
| Decision Date | Oct 29, 1996 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 892.1000 |
| Device Class | Class 2 |
| Attributes | Software as a Medical Device |
Intended Use
The TMS Brachytherapy Module, Version 3.0, is a 3D Radiotherapy Treatment Planning (RTP) system for radiation dose planning of patients undergoing interstitial or intracavitary treatment in the Oncology clinic. The system software is designed to function as an integrated part of the TMS (Treatment Management System) radiotherapy treatment planning system (K953391). The TMS Brachytherapy Module is used for planning the treatment only, not for performing the treatment.
Device Story
TMS Brachytherapy Version 3.0; integrated work module for 3D radiotherapy treatment planning; interstitial/intracavitary techniques. Inputs: clinical data for source channel definition, source positioning. Processing: manual optimization of source weights; calculation of dose distributions and point dose values in arbitrary sections; evaluation of treatment tactics. Output: radiation dose plans for clinical review. Used in oncology clinics by clinicians. Assists in treatment design; does not perform treatment. Benefits: facilitates precise radiation dose planning.
Clinical Evidence
Bench testing only. System performance verified against system requirements specifications and compared to predicate device; results indicate equivalent performance.
Technological Characteristics
3D Radiotherapy Treatment Planning (RTP) software module. Integrated with TMS radiotherapy treatment planning system. Functionality includes source channel definition, source positioning, manual source weight optimization, and dose distribution calculation.
Indications for Use
Indicated for patients undergoing interstitial or intracavitary radiation therapy requiring 3D treatment planning in an oncology clinic setting.
Regulatory Classification
Identification
A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).
Special Controls
*Classification.* Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
Predicate Devices
- PLATO Radiotherapy Treatment Planning System (K915622)
Reference Devices
- TMS (Treatment Management System) radiotherapy treatment planning system (K953391)
Related Devices
- K030821 — SIMUPLAN TREATMENT PLANNING SYSTEM, MODEL V. 7.5 · Simuplan S.L. · Sep 17, 2003
- K970236 — THERAPLAN PLUS VERSION 1.2 · Theratronics, Inc. · Jul 9, 1997
- K123263 — HDRPLUS, ADD IN PROSTATE MODULE FOR HDRPLUS · Eckert & Ziegler Bebig GmbH · Apr 4, 2013
- K153368 — Radiance V3 · Gmv Soluciones Globales Internet S.A.U. · Feb 16, 2016
- K132816 — ONCENTRA BRACHY · Nucletron B.V. · Jun 13, 2014